0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > CD200

CD200

CD200 Molecule Information

Name:OX-2 membrane glycoprotein
Target Synonym:OX-2 membrane glycoprotein;MOX1 ;MOX2;CD200;CD_antigen=CD200
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:2
Lastest Research Phase:Phase ?

CD200 Protein Product ListCompare or Buy

CD200 Molecule Synonym Name

CD200,MOX1,MOX2,MRC,OX-2,My033

CD200 Molecule Background

CD200 is also known as OX-2 membrane glycoprotein (OX-2), is a type-1 membrane glycoprotein, which contains two immunoglobulin domains (1 Ig-like C2-type (immunoglobulin-like) domain and Ig-like V-type (immunoglobulin-like) domain), and thus belongs to the immunoglobulin superfamily. CD200 / OX-2 is widely expressed in multiple cell types. CD200 interacts with a structurally related receptor (CD200R) expressed mainly on myeloid cells and is involved in regulation of macrophage and mast cell function. OX-2 / CD200 and CD200R associate via their respective N-terminal Ig-like domains. CD200 also plays an important role in prevention of graft rejection, autoimmune diseases and spontaneous abortion.

CD200 References

CD200 Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Samalizumab ALXN-6000 Phase Ⅱ Alexion Pharmaceuticals, The Leukemia & Lymphoma Society Acute myeloid Leukemia (AML) Details
AFM-24 AFM-12; AFM-18; AFM-20; AFM-21; AFM-22; AFM-24; AFM-24+; AFM-26; AFM-26+ Preclinical Affimed, Amphivena Therapeutics Colorectal cancer, Lung cancer, Acute myeloid Leukemia (AML), Head and neck cancer, Cancer Details

This web search service is supported by Google Inc.

totop